The mini-Budget in September 2022 had a dramatic impact on the Defined Benefit scheme landscape.
Within months, the focus of many trustee boards switched from strategic discussions on deficit management to deciding what to do with a healthy surplus. Buy-out seemed to be the default and obvious short-term option for many schemes at this point. But with insurers reaching full capacity, could ‘running-on’ your scheme be a sensible option?